It has also been reported that the combination of miR-135a, miR-193b, and miR-384, modulators of APP or BACE1 expression, are good for early AD diagnosis [124], demonstrating that a combined biomarker signature is better than a particular one for diagnosis. Here, APP is linked to Alzheimer disease.